MRNA

Leveraged & Inverse Channel

Direxion Launches New Nanotechnology ETF, TYNE

By Aaron NeuwirthNovember 23, 2021

Featured

Biotech ETFs Benefit From Moderna Dual Booster Shot News

By Ian YoungSeptember 9, 2021

Innovative ETFs Channel

Will Biotech ETFs Benefit from Biogen’s New Alzheimer’s Drug?

By Ian YoungJune 9, 2021

Featured

Biotech ETFs Pop Amid Pending J&J Vaccine Approval

By Ian YoungFebruary 24, 2021

Featured

Stock ETFs Consolidate on Stimulus Hopes and Unemployment Data

By Ian YoungJanuary 14, 2021

Featured

Moderna Helps Biotech ETFs Mitigate Massive Losses as Stocks Tumble

By Ian YoungJanuary 4, 2021

Innovative ETFs Channel

41 New Innovators Join Invesco QQQ Innovation Suite

By Aaron NeuwirthDecember 18, 2020

Featured

Biotech ETFs Remain Hot As Investors Await Upcoming Vaccine

By Ian YoungNovember 27, 2020

Disruptive Technology Channel

Why Bill Gates Is Betting Millions on Synthetic Biology

By Special To ETF TrendsSeptember 12, 2020

Expert Insights

ETF Edge: Tom Lydon Talks Tesla Snub By S&P 500

By Aaron NeuwirthSeptember 10, 2020

Featured

Moderna Vaccine Optimism Could Drive Biotech ETFs

By Ian YoungAugust 26, 2020

Nasdaq Investment Intelligence Channel

A Power Pharmaceuticals ETF to Consider

By Tom LydonJuly 27, 2020

Featured

Biotech ETFs To Explore As Race For Covid-19 Vaccine Heats Up

By Ian YoungJuly 22, 2020

Featured

Stock ETFs Struggle After Moderna Enthusiasm Fades

By Ian YoungJuly 15, 2020

Featured

Moderna Study Sends Biotech ETFs And Stock Futures Surging

By Ian YoungJuly 14, 2020

Featured

Stock Index ETFs Jump After Holiday Weekend Amid Reopening Optimism

By Ian YoungMay 26, 2020

Disruptive Technology Channel

This Is NOT 2008 All Over Again

By Special To ETF TrendsMay 23, 2020

Featured

AstraZeneca Joins Coronavirus Vaccine Race, Great For Biotech ETFs

By Ian YoungMay 21, 2020